Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply
Alimentary Pharmacology & Therapeutics · 04.11.2026
DOI: 10.1111/apt.70950 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 04.11.2026. Verfasst von Carmen Yagüe Caballero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, University Hospital Miguel Servet. Aragón Health Research Institute, Zaragoza, Spain. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Gastroenterology Department, University Hospital Miguel Servet. Aragón Health Research Institute, Zaragoza, Spain.
ORCID-Profile: Carmen Yagüe Caballero, Santiago García-López, Diego Casas-Deza
Zitieren
APA
Yagüe Caballero, C., García-López, S., Casas-Deza, D., & ENEIDA registry investigators (2026). Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70950
Vancouver
Yagüe Caballero C, García-López S, Casas-Deza D, ENEIDA registry investigators. Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70950
BibTeX
@article{YageCaballero2026,
author = {Yagüe Caballero, Carmen and García-López, Santiago and Casas-Deza, Diego and ENEIDA registry investigators, ENEIDA registry investigators},
title = {Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70950}
}
EUVIMED